Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: RLAY

Relay Therapeutics, Inc.

Healthcare | Biotechnology

No licensed closing price on file for RLAY. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-1.56

Relay Therapeutics, Inc. (NASDAQ: RLAY) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:58 UTC.

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-1.56

Revenue, margins & earnings

FY2021: net loss $364M on revenue $3M$3MFY2021FY2022: net loss $291M on revenue $1M$1MFY2022FY2023: net loss $342M on revenue $26M$26MFY2023FY2024: net loss $338M on revenue $10M$10MFY2024FY2025: net loss $276M on revenue $15M$15MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-08
  • 2026-10-08Chief Financial OfficerSale-17,511$325.4K
  • 2026-10-08President and CEOSale-48,199$872.4K
  • 2026-10-08Chief Financial OfficerSale-206$4.0K
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does Relay Therapeutics, Inc. do?

Relay Therapeutics, Inc. is a biotechnology company, listed on NASDAQ as RLAY.

When did RLAY last file with the SEC?

Relay Therapeutics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-09. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 07:58 UTC. This page is also available as JSON at /api/data?ticker=RLAY and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for RLAY and 5,000+ tickers.

Create a free account — keep RLAY
For your agent
GET /api/data?ticker=RLAY

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt